Found 119 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is van Breemen, Richard B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Cannabis
van Breemen RB, Simchuk D.  2023.  Antiviral activities of hemp cannabinoids.. Clin Sci (Lond). 137(8):633-643.
Carcinoma, Hepatocellular
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Catechin
Rush MD, Rue EA, Wong A, Kowalski P, Glinski JA, van Breemen RB.  2018.  Rapid Determination of Procyanidins Using MALDI-ToF/ToF Mass Spectrometry.. J Agric Food Chem. 66(43):11355-11361.
Chalcones
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Chemoembolization, Therapeutic
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Chlorocebus aethiops
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Chromatography, High Pressure Liquid
Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.  2018.  Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 32(22):1941-1948.
COVID-19
van Breemen RB, Muchiri RN.  2024.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.. Mass Spectrom Rev. 43(1):39-46.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
van Breemen RB, Simchuk D.  2023.  Antiviral activities of hemp cannabinoids.. Clin Sci (Lond). 137(8):633-643.
COVID-19 Drug Treatment
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Cytochrome P-450 CYP1A2
Liu J, Banuvar S, Viana M, Barengolts E, Chen S-N, Pauli GF, van Breemen RB.  2023.  Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.. Drug Metab Dispos. 51(2):199-204.
Cytochrome P-450 CYP2B6
Chen L, Nikolic D, Li G, Liu J, van Breemen RB.  2023.  In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis Fisch. ex DC.. Toxicol Sci. 196(1):16-24.
Cytochrome P-450 CYP2C8
Chen L, Nikolic D, Li G, Liu J, van Breemen RB.  2023.  In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis Fisch. ex DC.. Toxicol Sci. 196(1):16-24.
Cytochrome P-450 CYP2C9
Chen L, Nikolic D, Li G, Liu J, van Breemen RB.  2023.  In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis Fisch. ex DC.. Toxicol Sci. 196(1):16-24.
Liu J, Banuvar S, Viana M, Barengolts E, Chen S-N, Pauli GF, van Breemen RB.  2023.  Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.. Drug Metab Dispos. 51(2):199-204.
Cytochrome P-450 CYP2D6
Liu J, Banuvar S, Viana M, Barengolts E, Chen S-N, Pauli GF, van Breemen RB.  2023.  Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.. Drug Metab Dispos. 51(2):199-204.
Cytochrome P-450 CYP3A
Liu J, Banuvar S, Viana M, Barengolts E, Chen S-N, Pauli GF, van Breemen RB.  2023.  Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.. Drug Metab Dispos. 51(2):199-204.
Cytochrome P-450 Enzyme Inhibitors
Chen L, Nikolic D, Li G, Liu J, van Breemen RB.  2023.  In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis Fisch. ex DC.. Toxicol Sci. 196(1):16-24.
Cytochrome P-450 Enzyme System
Liu J, Banuvar S, Viana M, Barengolts E, Chen S-N, Pauli GF, van Breemen RB.  2023.  Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.. Drug Metab Dispos. 51(2):199-204.
Chen L, Nikolic D, Li G, Liu J, van Breemen RB.  2023.  In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis Fisch. ex DC.. Toxicol Sci. 196(1):16-24.
Dietary Supplements
Liu J, Banuvar S, Viana M, Barengolts E, Chen S-N, Pauli GF, van Breemen RB.  2023.  Pharmacokinetic Interactions of a Licorice Dietary Supplement with Cytochrome P450 Enzymes in Female Participants.. Drug Metab Dispos. 51(2):199-204.
Doxorubicin
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.

Pages